Evaluation of the potential developmental toxicity of cyclododecatriene (CDDT).
The potential maternal and developmental toxicity of cyclododecatriene (CDDT) was assessed in rats. Groups of 22 time-mated female Crl:CD (SD) BR rats were exposed by inhalation (whole-body, 6 h/day) to either 0 (control), 10, 25, or 67 ppm CDDT over days 6-20 of gestation (days 6-20 G); the day of copulation plug detection was designated day 0 G. The dams were euthanized on day 21 G, and their abdominal and thoracic viscera were examined grossly. The fetuses were weighed, sexed, and examined for external, visceral, and skeletal alterations. Evidence of maternal toxicity was seen at 25 and 67 ppm. There were compound-related reductions in maternal body weight and food consumption parameters as well as increased occurrences of wet and stained fur at these exposure levels. Developmental toxicity evident as reduced mean fetal weight and delayed skeletal ossification was seen only at 67 ppm. There was no evidence of either maternal or developmental toxicity at 10 ppm. Thus, the no-observed-effect level (NOEL) for maternal toxicity was 10 ppm, and the NOEL for developmental toxicity was 25 ppm. Because developmental toxicity was observed only after exposures that also produced signs of maternal toxicity, CDDT was not considered to be a selective developmental toxicant in the rat.
Munley
S M
SM
DuPont Haskell Laboratory for Toxicology and Industrial Medicine, 1090 Elkton Road, Newark, DE 19714, USA. susan.m.munley@usa.dupont.com
Kelly
D P
DP
Kennedy
G L
GL
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000280:Administration, Inhalation; D000818:Animals; D005314:Embryonic and Fetal Development / Q000187:drug effects; D005260:Female; D005865:Gestational Age; D006840:Hydrocarbons, Alicyclic / Q000008:administration & dosage / Q000633:toxicity*; D008098:Litter Size / Q000187:drug effects; D008297:Male; D010865:Pilot Projects; D011247:Pregnancy; D051381:Rats; D012098:Reproduction / Q000187:drug effects*
D006840:Hydrocarbons, Alicyclic; C121694:1,5,9-cyclododecatriene